Back Bay Life Science Advisors to Lead Fireside Chat with Myovant Sciences President & Chief Executive Officer, Lynn Seely at Convergence Forum 2018

Back Bay Life Science Advisors will again serve as a lead sponsor for the Convergence Forum. On May 11, Back Bay CEO Jonathan Gertler will host a discussion with former Medivation Founder and current Myovant Sciences President & Chief Executive Officer, Lynn Seely.Dr. Seely is known as “The Woman at the Center of The Biggest Biotech IPO of the Year,” but Back Bay knows her as so much more—from her work at Medivation, Anesiva, and others, to her training in journalism and medicine—Dr. Seely is an accomplished, respected, and visionary leader in the life science realm.Convergence Forum is a high-level thought-provoking event addressing many of the most significant promises and challenges facing the life science industry.View the agenda, see other companies participating, and request an invitation on the Convergence website at convergenceforum.com.